Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection

Journal of Infection

Volumn 52, Issue 2, 2006, Pages

  Papastathopoulos, Konstantinos ^a   Bouzas, Evridiki ^a   Naoum, George ^a   Vergados, Ioannis ^b   Tsiodras, Sotirios ^b  

^a HENRY DUNANT HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Harada's; Hepatitis C; Interferon alpha; Retinal; Ribavirin; Side effects

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID DERIVATIVE; INDOCYANINE GREEN; RIBAVIRIN;

ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HEPATITIS C; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; OPHTHALMOSCOPY; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; VOGT KOYANAGI SYNDROME;

ADRENAL CORTEX HORMONES; ADULT; ANTIVIRAL AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; RETINAL DETACHMENT; RIBAVIRIN; TREATMENT OUTCOME; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 31344474561     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.05.005     Document Type: Article

References (9)

1. R.W. Read G.N. Holland N.A. Rao K.F. Tabbara S. Ohno L. Arellanes-Garcia et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature Am J Ophthalmol 131 5 2001 647-652
2. P. Pivetti-Pezzi M. Accorinti R.A. Colabelli-Gisoldi M.P. Pirraglia Vogt-Koyanagi-Harada disease and HLA type in Italian patients Am J Ophthalmol 122 1996 889-891
3. H. Kobayashi T. Kokubo M. Takahashi K. Sato N. Miyokawa S. Kimura et al. Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient Immunogenetics 47 1998 398-403
4. K. Yamaki K. Gocho K. Hayakawa I. Kondo S. Sakuragi Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease J Immunol 165 12 2000 7323-7329
5. J.G. McHutchison S.C. Gordon E.R. Schiff M.L. Shiffman W.M. Lee V.K. Rustgi et al. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group N Engl J Med 339 1998 1485-1492
6. F.L. Dumoulin L. Leifeld T. Sauerbruch U. Spengler Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis Biomed Pharmacother 53 1999 242-254
7. T. Kawano M. Shigehira H. Uto T. Nakama J. Kato K. Hayashi et al. Retinal complications during interferon therapy for chronic hepatitis C Am J Gastroenterol 91 1996 309-313
8. D.L. Sylvestre A.R. Disston D.P. Bui Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy J Viral Hepat 10 2003 467-470
9. A. Kasahara A. Hiraide N. Tomita H. Iwahashi A. Imagawa N. Ohguro et al. Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C J Gastroenterol 39 2004 1106-1109